Page last updated: 2024-12-10

n-(4-acetamidobenzoyl)-l-glutamic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(4-acetamidobenzoyl)-L-glutamic acid: folic acid urinary catabolite [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3080868
SCHEMBL ID5285628
MeSH IDM0097478

Synonyms (15)

Synonym
n-(4-acetamidobenzoyl)-l-glutamic acid
4-acetamidobenzoyl-l-glutamate
l-glutamic acid, n-(4-(acetylamino)benzoyl)-
p-acetamidobenzoylglutamate
4-acetamidobenzoylglutamate
60474-41-1
apabglu
(2s)-2-[(4-acetamidobenzoyl)amino]pentanedioic acid
SCHEMBL5285628
p-acetylaminobenzoylglutamic acid
MGJNINDWRXYHBA-NSHDSACASA-N
n-{4-[(1-hydroxyethylidene)amino]benzoyl}glutamic acid
DTXSID00975885
(s)-2-(4-acetamidobenzamido)pentanedioic acid
(s)-2-(4-acetamidobenzamido)pentanedioicacid

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Dual-label stable isotope dilution assays for the simultaneous quantification of isotopologic folates in clinical samples offer the perspective for differentiating between unlabeled folates from endogenous body pools and administered [13C5]-labeled folates from a test dose when performing bioavailability trials."( Quantification of isotope-labeled and unlabeled folates and folate catabolites in urine samples by stable isotope dilution assay.
Büttner, BE; Köhler, P; Ohrvik, VE; Rychlik, M; Witthöft, CM, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (23.08)18.7374
1990's5 (38.46)18.2507
2000's4 (30.77)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.71 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (15.38%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]